Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study
Lancet Glob. Health
; 7(5): 613-623, May. 2019. tab, graf
Article
in English
| CONASS, Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP
| ID: biblio-1151005
Responsible library:
BR79.1
Localization: BR79.1
Full text:
Available
Collection:
National databases
/
Brazil
Health context:
SDG3 - Health and Well-Being
/
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
Health problem:
Target 3.4: Reduce premature mortality due to noncommunicable diseases
/
Cardiovascular Disease
Database:
CONASS
/
Sec. Est. Saúde SP
/
SESSP-IDPCPROD
Main subject:
Respiratory System
/
Cardiovascular Diseases
/
Risk Factors
/
Morbidity
/
Mortality
Type of study:
Controlled clinical trial
/
Etiology study
/
Observational study
/
Prognostic study
/
Risk factors
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
English
Journal:
Lancet Glob. Health
Year:
2019
Document type:
Article
Institution/Affiliation country:
Community Health & Epidemiology, St John's Research Institute/IN
/
Dante Pazzanese Institute of Cardiology/BR
/
Department of Community Health Sciences and Medicine, Aga Khan University/PK
/
Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia/MY
/
Department of Community Medicine and School of Public Health, Independent University/IN
/
Department of Medicine, University of Ottawa/CA
/
Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital/SE
/
Department of Pulmonary Medicine, Medical College, Thiruvananthapuram/IN
/
Department of Social Medicine, Medical University of Wroclaw/PL
/
Division of Endocrinology, Department of Internal Medicine, Medical Faculty of Istanbul University/TR